Projects

Novel Investigations on the Pathogenesis of Primary Podocytopathy using Nephrotic Syndrome Plasma and Podocyte Cultures

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - 2029

Project Lead

Dr. Anil Vasudevan

Authors

Dr. Anil Vasudevan, Dr. Niveditha Kamath & Dr. Swaminathan S

Project Status

ongoing

Project Type

IIISC intramural Grant